BNP Paribas Asset Management
NUVB icon

BNP Paribas Asset Management’s Nuvation Bio NUVB Stock Holding History

BNP Paribas Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.8K Buy
4,371
+1,043
+31% +$5.81K ﹤0.01% 2057
2025
Q4 		$30K Buy
3,328
+1,264
+61% +$7.83K ﹤0.01% 1824
2025
Q3 		$8K Sell
2,064
-272
-12% -$741 ﹤0.01% 1703
2025
Q2 		$5K Buy
+2,336
New +$4.87K ﹤0.01% 2029

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Asset Management's NUVB Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Nuvation Bio (NUVB) stake by 31% in Q1 2026, buying an estimated $5.81K and bringing the position to 4,371 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

BNP Paribas Asset Management first reported a position in NUVB in Q2 2025 and has held it in 4 quarters since. The position peaked at $30K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • BNP Paribas Asset Management held 4,371 shares of Nuvation Bio worth $18.8K as of Q1 2026.
  • BNP Paribas Asset Management bought 1,043 Nuvation Bio shares in Q1 2026, an estimated $5.81K.
  • Nuvation Bio made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2057 holding.
  • BNP Paribas Asset Management first reported a position in Nuvation Bio in Q2 2025 and has held it in 4 quarters since.
  • BNP Paribas Asset Management's Nuvation Bio position peaked at $30K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.